• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

走向溶瘤病毒治疗的预测性计算模型:实验验证和模型选择的基础

Towards predictive computational models of oncolytic virus therapy: basis for experimental validation and model selection.

作者信息

Wodarz Dominik, Komarova Natalia

机构信息

Department of Ecology and Evolution, University of California Irvine, Irvine, California, United States of America.

出版信息

PLoS One. 2009;4(1):e4271. doi: 10.1371/journal.pone.0004271. Epub 2009 Jan 30.

DOI:10.1371/journal.pone.0004271
PMID:19180240
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2629569/
Abstract

Oncolytic viruses are viruses that specifically infect cancer cells and kill them, while leaving healthy cells largely intact. Their ability to spread through the tumor makes them an attractive therapy approach. While promising results have been observed in clinical trials, solid success remains elusive since we lack understanding of the basic principles that govern the dynamical interactions between the virus and the cancer. In this respect, computational models can help experimental research at optimizing treatment regimes. Although preliminary mathematical work has been performed, this suffers from the fact that individual models are largely arbitrary and based on biologically uncertain assumptions. Here, we present a general framework to study the dynamics of oncolytic viruses that is independent of uncertain and arbitrary mathematical formulations. We find two categories of dynamics, depending on the assumptions about spatial constraints that govern that spread of the virus from cell to cell. If infected cells are mixed among uninfected cells, there exists a viral replication rate threshold beyond which tumor control is the only outcome. On the other hand, if infected cells are clustered together (e.g. in a solid tumor), then we observe more complicated dynamics in which the outcome of therapy might go either way, depending on the initial number of cells and viruses. We fit our models to previously published experimental data and discuss aspects of model validation, selection, and experimental design. This framework can be used as a basis for model selection and validation in the context of future, more detailed experimental studies. It can further serve as the basis for future, more complex models that take into account other clinically relevant factors such as immune responses.

摘要

溶瘤病毒是一类专门感染癌细胞并将其杀死的病毒,同时能使健康细胞基本保持完好。它们在肿瘤中扩散的能力使其成为一种颇具吸引力的治疗方法。尽管在临床试验中已观察到有前景的结果,但由于我们对病毒与癌症之间动态相互作用的基本原理缺乏了解,尚未取得确凿的成功。在这方面,计算模型有助于实验研究优化治疗方案。虽然已经开展了初步的数学研究,但这些研究存在个体模型很大程度上具有随意性且基于生物学上不确定假设的问题。在此,我们提出一个研究溶瘤病毒动力学的通用框架,该框架独立于不确定且随意的数学公式。根据关于病毒在细胞间传播的空间限制的假设,我们发现了两类动力学。如果感染细胞与未感染细胞混合在一起,存在一个病毒复制率阈值,超过该阈值后肿瘤控制是唯一结果。另一方面,如果感染细胞聚集在一起(例如在实体瘤中),那么我们会观察到更复杂的动力学,治疗结果可能朝任何一个方向发展,这取决于细胞和病毒的初始数量。我们将模型与先前发表的实验数据进行拟合,并讨论模型验证、选择和实验设计的相关方面。这个框架可作为未来更详细实验研究中模型选择和验证的基础。它还可以作为未来考虑其他临床相关因素(如免疫反应)的更复杂模型的基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef1/2629569/9382830857ba/pone.0004271.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef1/2629569/93c5ae2f5047/pone.0004271.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef1/2629569/1f758cb72a38/pone.0004271.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef1/2629569/1fe2168f5dc6/pone.0004271.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef1/2629569/e4a2e387ff31/pone.0004271.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef1/2629569/decdaf739b78/pone.0004271.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef1/2629569/617a16b37d6a/pone.0004271.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef1/2629569/9382830857ba/pone.0004271.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef1/2629569/93c5ae2f5047/pone.0004271.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef1/2629569/1f758cb72a38/pone.0004271.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef1/2629569/1fe2168f5dc6/pone.0004271.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef1/2629569/e4a2e387ff31/pone.0004271.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef1/2629569/decdaf739b78/pone.0004271.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef1/2629569/617a16b37d6a/pone.0004271.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef1/2629569/9382830857ba/pone.0004271.g007.jpg

相似文献

1
Towards predictive computational models of oncolytic virus therapy: basis for experimental validation and model selection.走向溶瘤病毒治疗的预测性计算模型:实验验证和模型选择的基础
PLoS One. 2009;4(1):e4271. doi: 10.1371/journal.pone.0004271. Epub 2009 Jan 30.
2
ODE models for oncolytic virus dynamics.溶瘤病毒动力学的 ODE 模型。
J Theor Biol. 2010 Apr 21;263(4):530-43. doi: 10.1016/j.jtbi.2010.01.009. Epub 2010 Jan 18.
3
Complex spatial dynamics of oncolytic viruses in vitro: mathematical and experimental approaches.体外溶瘤病毒的复杂空间动力学:数学和实验方法。
PLoS Comput Biol. 2012;8(6):e1002547. doi: 10.1371/journal.pcbi.1002547. Epub 2012 Jun 14.
4
Computational modeling approaches to studying the dynamics of oncolytic viruses.计算建模方法在研究溶瘤病毒动力学中的应用。
Math Biosci Eng. 2013 Jun;10(3):939-57. doi: 10.3934/mbe.2013.10.939.
5
Permissiveness of human cancer cells to oncolytic bovine herpesvirus 1 is mediated in part by KRAS activity.人类癌细胞对溶瘤牛疱疹病毒 1 的易感性部分是由 KRAS 活性介导的。
J Virol. 2014 Jun;88(12):6885-95. doi: 10.1128/JVI.00849-14. Epub 2014 Apr 2.
6
The replicability of oncolytic virus: defining conditions in tumor virotherapy.溶瘤病毒的可重复性:肿瘤病毒疗法中的定义条件。
Math Biosci Eng. 2011 Jul;8(3):841-60. doi: 10.3934/mbe.2011.8.841.
7
Oncolytic potency and reduced virus tumor-specificity in oncolytic virotherapy. A mathematical modelling approach.溶瘤病毒疗法中的溶瘤效力与病毒肿瘤特异性降低:一种数学建模方法
PLoS One. 2017 Sep 21;12(9):e0184347. doi: 10.1371/journal.pone.0184347. eCollection 2017.
8
Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.在具有复制能力的腺病毒背景下抗凋亡蛋白与肿瘤坏死因子的功能相互作用。
Gene Ther. 2005 Sep;12(17):1333-46. doi: 10.1038/sj.gt.3302555.
9
Modelling heterogeneity in viral-tumour dynamics: The effects of gene-attenuation on viral characteristics.病毒-肿瘤动力学中的异质性建模:基因衰减对病毒特征的影响。
J Theor Biol. 2018 Oct 7;454:41-52. doi: 10.1016/j.jtbi.2018.05.030. Epub 2018 May 29.
10
Estimation of Oncolytic Virus Populations within Tumors.肿瘤内溶瘤病毒群体的估算。
Cancer Res. 2018 Oct 15;78(20):5992-6000. doi: 10.1158/0008-5472.CAN-18-0447. Epub 2018 Aug 16.

引用本文的文献

1
CAR T-cell and oncolytic virus dynamics and determinants of combination therapy success for glioblastoma.嵌合抗原受体T细胞和溶瘤病毒治疗胶质母细胞瘤的动力学及联合治疗成功的决定因素
bioRxiv. 2025 Jan 25:2025.01.23.634499. doi: 10.1101/2025.01.23.634499.
2
A comparative analysis of 2D and 3D experimental data for the identification of the parameters of computational models.二维和三维实验数据的对比分析用于计算模型参数的识别。
Sci Rep. 2023 Sep 22;13(1):15769. doi: 10.1038/s41598-023-42486-3.
3
An Agent-Based Model of Combination Oncolytic Viral Therapy and Anti-PD-1 Immunotherapy Reveals the Importance of Spatial Location When Treating Glioblastoma.

本文引用的文献

1
When individual behaviour matters: homogeneous and network models in epidemiology.当个体行为起作用时:流行病学中的同质模型和网络模型
J R Soc Interface. 2007 Oct 22;4(16):879-91. doi: 10.1098/rsif.2007.1100.
2
Oncolytic viruses in cancer therapy.溶瘤病毒在癌症治疗中的应用
Cancer Lett. 2007 Sep 8;254(2):178-216. doi: 10.1016/j.canlet.2007.02.002. Epub 2007 Mar 23.
3
From ONYX-015 to armed vaccinia viruses: the education and evolution of oncolytic virus development.从ONYX-015到武装痘苗病毒:溶瘤病毒开发的历程与演进
一种基于主体的溶瘤病毒联合抗PD-1免疫疗法治疗胶质母细胞瘤的模型揭示了治疗时空间位置的重要性。
Cancers (Basel). 2021 Oct 22;13(21):5314. doi: 10.3390/cancers13215314.
4
Modeling Oncolytic Viral Therapy, Immune Checkpoint Inhibition, and the Complex Dynamics of Innate and Adaptive Immunity in Glioblastoma Treatment.胶质母细胞瘤治疗中溶瘤病毒疗法、免疫检查点抑制以及先天免疫和适应性免疫复杂动力学的建模
Front Physiol. 2020 Mar 3;11:151. doi: 10.3389/fphys.2020.00151. eCollection 2020.
5
Backward Hopf bifurcation in a mathematical model for oncolytic virotherapy with the infection delay and innate immune effects.带感染时滞和固有免疫效应的溶瘤病毒治疗的数学模型中的反向 Hopf 分支。
J Biol Dyn. 2019 Dec;13(1):733-748. doi: 10.1080/17513758.2019.1667443. Epub 2019 Sep 18.
6
Investigating Macrophages Plasticity Following Tumour-Immune Interactions During Oncolytic Therapies.溶瘤疗法期间肿瘤-免疫相互作用后巨噬细胞可塑性的研究
Acta Biotheor. 2019 Dec;67(4):321-359. doi: 10.1007/s10441-019-09357-9. Epub 2019 Aug 13.
7
Spatial Model for Oncolytic Virotherapy with Lytic Cycle Delay.溶瘤病毒治疗中具有溶周期延迟的空间模型。
Bull Math Biol. 2019 Jul;81(7):2396-2427. doi: 10.1007/s11538-019-00611-2. Epub 2019 May 14.
8
Developing a Minimally Structured Mathematical Model of Cancer Treatment with Oncolytic Viruses and Dendritic Cell Injections.构建一个关于溶瘤病毒和树突状细胞注射癌症治疗的最小结构数学模型。
Comput Math Methods Med. 2018 Oct 30;2018:8760371. doi: 10.1155/2018/8760371. eCollection 2018.
9
Imaging, Tracking and Computational Analyses of Virus Entry and Egress with the Cytoskeleton.利用细胞骨架对病毒进入和离开进行成像、跟踪和计算分析。
Viruses. 2018 Mar 31;10(4):166. doi: 10.3390/v10040166.
10
The Role of the Innate Immune System in Oncolytic Virotherapy.天然免疫系统在溶瘤病毒疗法中的作用
Comput Math Methods Med. 2017;2017:6587258. doi: 10.1155/2017/6587258. Epub 2017 Dec 12.
Curr Cancer Drug Targets. 2007 Mar;7(2):133-9. doi: 10.2174/156800907780058862.
4
Oncolytic viruses: what's next?溶瘤病毒:接下来会怎样?
Curr Cancer Drug Targets. 2007 Mar;7(2):127-31. doi: 10.2174/156800907780058844.
5
History of oncolytic viruses: genesis to genetic engineering.溶瘤病毒的历史:起源到基因工程
Mol Ther. 2007 Apr;15(4):651-9. doi: 10.1038/sj.mt.6300108. Epub 2007 Feb 13.
6
Naturally oncolytic viruses.天然溶瘤病毒
Curr Opin Mol Ther. 2006 Aug;8(4):314-21.
7
Expression of the coxsackievirus- and adenovirus receptor in gastrointestinal cancer correlates with tumor differentiation.柯萨奇病毒和腺病毒受体在胃肠道癌中的表达与肿瘤分化相关。
Cancer Gene Ther. 2006 Aug;13(8):792-7. doi: 10.1038/sj.cgt.7700947. Epub 2006 Apr 21.
8
Cancer scene investigation: how a cold virus became a tumor killer.癌症现场调查:一种感冒病毒如何成为肿瘤杀手。
Future Oncol. 2005 Apr;1(2):247-58. doi: 10.1517/14796694.1.2.247.
9
Mathematical modeling of tumor therapy with oncolytic viruses: regimes with complete tumor elimination within the framework of deterministic models.溶瘤病毒肿瘤治疗的数学建模:确定性模型框架内实现肿瘤完全消除的方案
Biol Direct. 2006 Feb 17;1:6. doi: 10.1186/1745-6150-1-6.
10
Glioma virotherapy: effects of innate immune suppression and increased viral replication capacity.胶质瘤病毒疗法:先天性免疫抑制和病毒复制能力增强的影响
Cancer Res. 2006 Feb 15;66(4):2314-9. doi: 10.1158/0008-5472.CAN-05-2661.